名古屋大学大学院医学系研究科消化器疾患病態論寄附講座助教

2010年1月 - 2010年12月

名古屋大学大学院医学系研究科客員研究者

2009年10月 - 2009年12月

テキサス大学ＭＤアンダーソンがんセンター博士研究員

2008年4月 - 2009年9月

名古屋大学医学部附属病院病院助手

2005年7月 - 2008年3月

名古屋大学医学部附属病院消化器内科医員

2004年4月 - 2005年6月

国立名古屋病院消化器科医師

1998年7月 - 2000年9月

愛知県済生会病院消化器科医師

1997年4月 - 1998年6月

三井記念病院内科医師

1992年5月 - 1997年3月

日本消化器内視鏡学会   消化器内視鏡専門医、指導医

日本臨床薬理学会   社員（評議員）

日本癌学会

日本癌治療学会

日本緩和医療学会

日本消化器がん検診学会

日本臨床栄養代謝学会

Alteration of gene expression and DNA methylation in drug-resistant gastric cancer 査読有り

Osamu Maeda, Takafumi Ando, Naoki Ohmiya, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Yoko Hibi, Taku Nagai, Kiyofumi Yamada, Hidemi Goto

Oncology Reports   31 巻   頁： 1883-1890   2014年

Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cells 査読有り

Osamu Maeda, Masashi Kondo, Takayoshi Fujita, Noriyasu Usami, Takayuki Fukui, Kaoru Shimokata, Takafumi Ando, Hidemi Goto, Yoshitaka Sekido

Oncology Reports   16 巻 ( 1 ) 頁： 91-96   2006年7月

Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line 査読有り

Osamu Maeda, Noriyasu Usami, Masashi Kondo, Masahide Takahashi, Hidemi Goto, Kaoru Shimokata, Kazuo Kusugami, Yoshitaka Sekido

Oncogene   23 巻   頁： 964-972   2004年

Chemotherapy for biliary tract cancer: real-world experience in a single institute 査読有り

Maeda, O; Ebata, T; Shimokata, T; Matsuoka, A; Inada-Inoue, M; Morita, S; Takano, Y; Urakawa, H; Miyai, Y; Sugishita, M; Mitsuma, A; Ando, M; Mizuno, T; Nagino, M; Ando, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE   82 巻 ( 4 ) 頁： 725 - 733   2020年11月

Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review 査読有り

Maeda, O; Ohka, F; Maesawa, S; Matsuoka, A; Shimokata, T; Mitsuma, A; Urakawa, H; Nakamura, S; Shimoyamas, Y; Nakaguro, SM; Wakabayashi, T; Ando, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE   82 巻 ( 4 ) 頁： 631 - 644   2020年11月

5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Letter 査読有り

Maeda, O; Shimokata, T; Ando, Y

CLINICAL CANCER RESEARCH   26 巻 ( 14 ) 頁： 3889 - 3889   2020年7月

Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapy 査読有り

Maeda, O; Matsuoka, A; Furukawa, K; Miyahara, R; Hirooka, Y; Ando, Y

MOLECULAR AND CLINICAL ONCOLOGY   11 巻 ( 1 ) 頁： 91 - 98   2019年7月

Cabozantinib in Hepatocellular Carcinoma

Maeda, O; Ando, Y

NEW ENGLAND JOURNAL OF MEDICINE   379 巻 ( 14 ) 頁： 1384 - 1384   2018年10月

Nivolumab for the treatment of malignant melanoma in a patient with pre-existing myasthenia gravis 査読有り

Osamu Maeda, Kenji Yokota, Naoki Atsuta, Masahisa Katsuno, Masashi Akiyama, Yuichi Ando

Nagoya Journal of Medical Science   78 巻 ( 1 ) 頁： 119-122   2016年2月

Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer 査読有り

Osamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Masanao Nakamura, Kohei Funasaka, Kazuhiro Furukawa, Yuichi Ando, Hidemi Goto

Molecular and Clinical Oncology   2 巻 ( 6 ) 頁： 1103-1106   2014年11月

A patient with esophageal cancer with bone metastasis who achieved pain relief with repetitive administration of strontium-89 chloride 査読有り

Osamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Masanao Nakamura, Kohei Funasaka, Kazuhiro Furukawa, Yuichi Ando, Katsuhiko Kato, Hidemi Goto

Clinical Journal of Gastroenterology   7 巻 ( 5 ) 頁： 387-391   2014年7月

A case of gastric carcinosarcoma with distant metastasis for which chemotherapy with S-1 plus cisplatin was transiently effective 査読有り

Osamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Tomoko Miyata, Keita Itatsu, Yuichi Ando, Hidemi Goto

International Cancer Conference Journal   3 巻   頁： 252-259   2014年2月

DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: a mini review 査読有り

Osamu Maeda, Takafumi Ando, Osamu Watanabe, Kazuhiro Ishiguro, Naoki Ohmiya, Yasumasa Niwa, Hidemi Goto

Inflammopharmacology   14 巻 ( 5-6 ) 頁： 204-206   2006年12月

Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin 査読有り

Osamu Maeda, Hiroaki Iwase, Naoto Mamiya, Motosuke Nakamura, Tomokazu Mizuno, Yuji Nishio, Takafumi Ando, Kenji Ina, Kazuo Kusugami

Internal Medicine   39 巻   頁： 239-244   2000年

食道癌の術前化学療法のエビデンス

前田 修

外科   85 巻 ( 10 ) 頁： 1089 - 1094   2023年9月

消化管がん薬物療法の進歩

前田修

BIO Clinica   38 巻 ( 1 ) 頁： 26 - 30   2023年1月

有害事象(副作用)への対応とケアQ&A　化学療法の有害事象(副作用)、予防と対策

前田修

消化器ナーシング   27 巻 ( 12 ) 頁： 1113 - 1118   2022年12月

膵・消化管神経内分泌腫瘍

前田修

腫瘍内科   30 巻 ( 5 ) 頁： 487 - 491   2022年11月

外来療法中の悪心・嘔吐,発熱,ポート管理

前田修

臨床消化器内科   37 巻 ( 11 ) 頁： 1439 - 1443   2022年9月

食道癌の診療　食道癌に対する集学的治療　周術期補助療法

前田修

臨床消化器内科   37 巻 ( 9 ) 頁： 1149 - 1153   2022年8月

非切除悪性肝門部胆管狭窄に対する抗腫瘍療法

前田修、江畑智希

消化器内視鏡   34 巻 ( 6 ) 頁： 1144 - 1149   2022年6月

分子標的薬による肝障害の特徴と対策

前田修,安藤雄一

腫瘍内科   18 巻 ( 5 ) 頁： 461-466   2016年11月

ＤＮＡメチル化と正常大腸 ー特に field cancerization についてー

前田 修, 安藤貴文, 石黒和博, 渡辺修, 日比陽子, 永井拓, 山田清文, 舩坂好平, 宮原良二, 大宮直木, 後藤秀実, Jean-Pierre J.Issa

生物物理化学   56 巻   頁： 00   2012年

緊急を要する重症肝胆膵疾患の診断とその対策　肝臓　特発性細菌性腹膜炎

前田修, 鵜沼直雄

肝・胆・膵   33 巻 ( 5 ) 頁： 667-672   1996年11月

視床下部症候群で発症し長期経過観察しえたヒスチオサイトーシスXの１剖検例

前田修，山門実，佐々木憲夫，田中茂，菅原修，高梨利一郎，中尾一和

ホルモンと臨床   43 巻 ( 増刊 ) 頁： 42-45   1995年1月

Ca,P,多価イオン代謝異常症 PTH related proteinによる高Ca血症ならびにACTHによる低K血症を呈した肺小細胞癌の1症例

前田修, 杉本徳一郎, 山門実, 他

臨床体液   21 巻 ( 1 ) 頁： 13-16   1994年10月

検査値の読み方 特異な皮膚の色をきっかけにヘモクロマトーシスと診断しえた症例

前田修, 鵜沼直雄

臨床消化器内科   9 巻 ( 12 ) 頁： 1929-1934   1994年10月

Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitors.

Liang Y, Maeda O, Nishida K, Chretien B, Ando Y

Cancer science     2025年1月

Effects of <i>KRAS</i>, <i>STK11</i>, <i>KEAP1</i>, and <i>TP53</i> mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma

Liang, Y; Maeda, O; Kondo, C; Nishida, K; Ando, Y

PLOS ONE   19 巻 ( 7 ) 頁： e0307580   2024年7月

Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer 査読有り

Liang, Y; Maeda, O; Miyata, K; Kanda, M; Sugita, S; Shimizu, D; Nishida, K; Kodera, Y; Ando, Y

CANCER CHEMOTHERAPY AND PHARMACOLOGY   93 巻 ( 2 ) 頁： 121 - 127   2024年2月

Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

Liang, Y; Maeda, O; Ando, Y

JAPANESE JOURNAL OF CLINICAL ONCOLOGY   54 巻 ( 4 ) 頁： 365 - 375   2024年1月

Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer 査読有り

Kataoka, K; Ohno, E; Ishikawa, T; Yamao, K; Mizutani, Y; Iida, T; Takami, H; Maeda, O; Yamaguchi, J; Yokoyama, Y; Ebata, T; Kodera, Y; Kawashima, H

CLINICAL ENDOSCOPY   57 巻 ( 1 ) 頁： 112 - 121   2024年1月

Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcoma 査読有り

Liang, Y; Maeda, O; Shimokata, T; Yokota, K; Koike, H; Sakai, T; Ikuta, K; Urakawa, H; Nishida, Y; Akiyama, M; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL   13 巻 ( 1 ) 頁： 63 - 67   2024年1月

Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA &gt; 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer 査読有り

Nakanishi, K; Tanaka, C; Kanda, M; Miyata, K; Furukawa, K; Maeda, O; Shimizu, D; Sugita, S; Kakushima, N; Furune, S; Kawashima, H; Ando, Y; Ebata, T; Kodera, Y

CANCERS   15 巻 ( 21 )   2023年11月

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition 査読有り

Mishima, S; Naito, Y; Akagi, K; Hayashi, N; Hirasawa, A; Hishiki, T; Igarashi, A; Ikeda, M; Kadowaki, S; Kajiyama, H; Kato, M; Kenmotsu, H; Kodera, Y; Komine, K; Koyama, T; Maeda, O; Miyachi, M; Nishihara, H; Nishiyama, H; Ohga, S; Okamoto, W; Oki, E; Ono, S; Sanada, M; Sekine, I; Takano, T; Tao, KYK; Terashima, K; Tsuchihara, K; Yatabe, Y; Yoshino, T; Baba, E

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   28 巻 ( 10 ) 頁： 1237 - 1258   2023年10月

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors 査読有り

Mishima, S; Naito, Y; Akagi, K; Hayashi, N; Hirasawa, A; Hishiki, T; Igarashi, A; Ikeda, M; Kadowaki, S; Kajiyama, H; Kato, M; Kenmotsu, H; Kodera, Y; Komine, K; Koyama, T; Maeda, O; Miyachi, M; Nishihara, H; Nishiyama, H; Ohga, S; Okamoto, W; Oki, E; Ono, S; Sanada, M; Sekine, I; Takano, T; Tao, KYK; Terashima, K; Tsuchihara, K; Yatabe, Y; Yoshino, T; Baba, E

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   28 巻 ( 8 ) 頁： 941 - 955   2023年8月

A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomy 査読有り

Liang, Y; Maeda, O; Miyata, K; Tanaka, C; Kanda, M; Shimizu, D; Fukaya, M; Koike, M; Kodera, Y; Ando, Y

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY     2023年7月

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors 査読有り

Naito, Y; Mishima, S; Akagi, K; Hayashi, N; Hirasawa, A; Hishiki, T; Igarashi, A; Ikeda, M; Kadowaki, S; Kajiyama, H; Kato, M; Kenmotsu, H; Kodera, Y; Komine, K; Koyama, T; Maeda, O; Miyachi, M; Nishihara, H; Nishiyama, H; Ohga, S; Okamoto, W; Oki, E; Ono, S; Sanada, M; Sekine, I; Takano, T; Tao, K; Terashima, K; Tsuchihara, K; Yatabe, Y; Yoshino, T; Baba, E

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   28 巻 ( 7 ) 頁： 827 - 840   2023年7月

Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis 査読有り

Yamamoto, T; Mizuno, K; Ito, T; Yokoyama, S; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Ishikawa, T; Kanamori, A; Yasuda, S; Toyoda, H; Yokota, K; Hase, T; Nishio, N; Maeda, O; Ishii, M; Sone, M; Ando, Y; Akiyama, M; Ishigami, M; Kawashima, H

INVESTIGATIONAL NEW DRUGS   41 巻 ( 3 ) 頁： 512 - 521   2023年6月

Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer 査読有り

Liang, Y; Maeda, O; Miyata, K; Kanda, M; Shimizu, D; Sugita, S; Okada, T; Ito, J; Kawamura, M; Ishihara, S; Nakatochi, M; Ando, M; Kodera, Y; Ando, Y

MOLECULAR AND CLINICAL ONCOLOGY   18 巻 ( 4 ) 頁： 34   2023年4月

Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury

Yamamoto, T; Morooka, H; Ito, T; Ishigami, M; Mizuno, K; Yokoyama, S; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Yokota, K; Hase, T; Maeda, O; Hashimoto, N; Ando, Y; Akiyama, M; Kawashima, H

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   38 巻 ( 2 ) 頁： 251 - 258   2023年2月

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases

Maeda, O

NAGOYA JOURNAL OF MEDICAL SCIENCE   85 巻 ( 1 ) 頁： 33 - 34   2023年2月

Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study

Maeda, O; Fukaya, M; Koike, M; Miyata, K; Kanda, M; Nishida, K; Ando, M; Kodera, Y; Ando, Y

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY   18 巻 ( 6 ) 頁： 578 - 585   2022年12月

Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)

Yamaguchi, J; Yokoyama, Y; Fujii, T; Yamada, S; Takami, H; Kawashima, H; Ohno, E; Ishikawa, T; Maeda, O; Ogawa, H; Kodera, Y; Nagino, M; Ebata, T

ANNALS OF SURGERY   275 巻 ( 6 ) 頁： 1043 - 1049   2022年6月

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

Furune, S; Kondo, C; Takano, Y; Shimokata, T; Sugishita, M; Mitsuma, A; Maeda, O; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL   11 巻 ( 1 ) 頁： 46 - 48   2022年1月

Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer

Takano, Y; Furune, S; Miyai, Y; Morita, S; Inoue, M; Shimokata, T; Sugishita, M; Mitsuma, A; Maeda, O; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL   11 巻 ( 1 ) 頁： 67 - 70   2022年1月

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

Kanda, M; Shimizu, D; Miyata, K; Maeda, O; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Ando, M; Kuwatsuka, Y; Murotani, K; Nakayama, G; Koike, M; Ando, Y; Ebata, T; Kodera, Y

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS   24 巻   頁： 100853   2021年12月

Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival

Yamada, K; Sawada, T; Nakamura, M; Yamamura, T; Maeda, K; Ishikawa, E; Iida, T; Mizutani, Y; Kakushima, N; Ishikawa, T; Furukawa, K; Ohno, E; Honda, T; Kawashima, H; Ishigami, M; Furune, S; Hase, T; Yokota, K; Maeda, O; Hashimoto, N; Akiyama, M; Ando, Y; Fujishiro, M

WORLD JOURNAL OF GASTROENTEROLOGY   27 巻 ( 41 ) 頁： 7190 - 7206   2021年11月

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Ito, T; Ishigami, M; Yamamoto, T; Mizuno, K; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Kawashima, H; Yasuda, S; Toyoda, H; Yokota, K; Hase, T; Nishio, N; Maeda, O; Kato, M; Hashimoto, N; Hibi, H; Kodera, Y; Sone, M; Ando, Y; Akiyama, M; Shimoyama, Y; Fujishiro, M

HEPATOLOGY INTERNATIONAL   15 巻 ( 5 ) 頁： 1278 - 1287   2021年10月

Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma: A propensity score-adjusted analysis

Takahashi, D; Mizuno, T; Yokoyama, Y; Igami, T; Yamaguchi, J; Onoe, S; Watanabe, N; Maeda, O; Ando, M; Ebata, T

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   28 巻 ( 9 ) 頁： 716 - 726   2021年9月

Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5′-Deoxy-5-fluorocytidine, and Creatinine Clearance

Inaishi, T; Fujita, KI; Matsumoto, N; Shimokata, T; Maeda, O; Kikumori, T; Hattori, N; Nakayama, G; Ando, Y

IN VIVO   34 巻 ( 6 ) 頁： 3539 - 3544   2020年11月

What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer?

Ogura, A; Uehara, K; Aiba, T; Hattori, N; Nakayama, G; Maeda, O; Ando, Y; Kodera, Y; Ebata, T; Nagino, M

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE   35 巻 ( 11 ) 頁： 2073 - 2080   2020年11月

Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort study

Urakawa, H; Ando, Y; Hase, T; Kikumori, T; Arai, E; Maeda, O; Mitsuma, A; Sugishita, M; Shimokata, T; Ikuta, K; Ishiguro, N; Nishida, Y

INTERNATIONAL JOURNAL OF CANCER   146 巻 ( 12 ) 頁： 3504 - 3515   2020年6月

Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

Mizuno, K; Ito, T; Ishigami, M; Ishizu, Y; Kuzuya, T; Honda, T; Kawashima, H; Inukai, Y; Toyoda, H; Yokota, K; Hase, T; Maeda, O; Kiyoi, H; Nagino, M; Hibi, H; Kodera, Y; Fujimoto, Y; Sone, M; Gotoh, M; Ando, Y; Akiyama, M; Hasegawa, Y; Fujishiro, M

JOURNAL OF GASTROENTEROLOGY   55 巻 ( 6 ) 頁： 653 - 661   2020年6月

Nonexposed wall-inversion surgery as a novel local resection method for neoplasms in the gastrointestinal tract

Fujishiro, M; Furukawa, K; Yamamura, T; Nakamura, M; Honda, T; Maeda, O; Ishigami, M; Kawashima, H

NAGOYA JOURNAL OF MEDICAL SCIENCE   82 巻 ( 2 ) 頁： 175 - 182   2020年5月

Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

Naito, Y; Mishima, S; Akagi, K; Igarashi, A; Ikeda, M; Okano, S; Kato, S; Takano, T; Tsuchihara, K; Terashima, K; Nishihara, H; Nishiyama, H; Hiyama, E; Hirasawa, A; Hosoi, H; Maeda, O; Yatabe, Y; Okamoto, W; Ono, S; Kajiyama, H; Nagashima, F; Hatanaka, Y; Miyachi, M; Kodera, Y; Yoshino, T; Taniguchi, H

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   25 巻 ( 3 ) 頁： 403 - 417   2020年3月

Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition

Mishima, S; Taniguchi, H; Akagi, K; Baba, E; Fujiwara, Y; Hirasawa, A; Ikeda, M; Maeda, O; Muro, K; Nishihara, H; Nishiyama, H; Takano, T; Tsuchihara, K; Yatabe, Y; Kodera, Y; Yoshino, T

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   25 巻 ( 2 ) 頁： 217 - 239   2020年2月

Detection of bacteria in blood circulation in patients receiving cancer chemotherapy

Ota, A; Morita, S; Matsuoka, A; Shimokata, T; Maeda, O; Mitsuma, A; Yagi, T; Asahara, T; Ando, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   25 巻 ( 1 ) 頁： 210 - 215   2020年1月

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study

Takano, N; Yamada, S; Hirakawa, A; Yokoyama, Y; Kawashima, H; Maeda, O; Okada, T; Ohno, E; Yamaguchi, J; Ishikawa, T; Sonohara, F; Suenaga, M; Takami, H; Hayashi, M; Niwa, Y; Hirooka, Y; Ito, Y; Naganawa, S; Ando, Y; Nagino, M; Goto, H; Fuji, T; Kodera, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE   81 巻 ( 2 ) 頁： 233 - 239   2019年5月

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

Yamada, S; Fujii, T; Yokoyama, Y; Kawashima, H; Maeda, O; Suzuki, K; Okada, T; Ono, E; Yamaguchi, J; Takano, N; Takami, H; Hayashi, M; Niwa, Y; Hirooka, Y; Ito, Y; Naganawa, S; Ando, Y; Nagino, M; Goto, H; Kodera, Y

CANCER CHEMOTHERAPY AND PHARMACOLOGY   81 巻 ( 5 ) 頁： 815 - 821   2018年5月

Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan

Morita, S; Kikumori, T; Tsunoda, N; Inaishi, T; Adachi, Y; Ota, A; Shibata, M; Matsuoka, A; Nakanishi, K; Takeuchi, D; Mizutani, T; Shimokata, T; Hayashi, H; Maeda, O; Ando, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   23 巻 ( 1 ) 頁： 195 - 200   2018年2月

Lung Metastases from Bile Duct Adenocarcinoma Mimicking Chronic Airway Infection and Causing Diagnostic Difficulty

Sato, M; Okachi, S; Fukihara, J; Shimoyama, Y; Wakahara, K; Sakakibara, T; Hase, T; Onishi, Y; Ogura, Y; Maeda, O; Hasegawa, Y

INTERNAL MEDICINE   57 巻 ( 10 ) 頁： 1429 - 1432   2018年

大腸の腫瘍および炎症性疾患におけるＤＮＡメチル化異常

前田修，安藤貴文，後藤秀実

第19回　日本消化器関連学会週間 

DNA hypermethylation and hypomethylation in colorectal cancer

DNA methylation analysis using microarray and its application to diagnostic markers of colorectal cancer

The 69th Annual Meeting of the Japanese Cancer Association 

Analysis of DNA hypermethylation in colon cancer cells using microarray 国際会議

American Association for Cancer Research 100th Annual Meeting 2009 

DNA hypermethylation in colorectal polyps and inflammatory bowel disease 国際会議

the 12th International Conference on Ulcer Research 

Beta-catenin potentially acts as a coactivator of GLI1 国際会議

The United European Gastroenterology Week (UEGW)